# Strategies for Delivering Anti-HIV Therapy in South Africa

> **NCT00080522** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 813 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BEHAVIORAL:** Monitoring by HIV-trained primary care nurses
- **BEHAVIORAL:** Community-based directly observed therapy (DOT)
- **DRUG:** stavudine
- **DRUG:** lamivudine
- **DRUG:** efavirenz
- **DRUG:** zidovudine
- **DRUG:** didanosine
- **DRUG:** lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT00080522
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 813 (—)
- **Last updated:** 2007-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080522, "Strategies for Delivering Anti-HIV Therapy in South Africa". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT00080522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*